Biopharmaceutics & drug disposition - JoVE Visualize

Showing results (1631-1640 of 2,133) with videos related to

Pageof 214

Sort By:

Biopharmaceutics & Drug Disposition|March 23, 1999

Use of mean residence time to determine the magnitude of difference between rate constants and to calculate tmax in the Bateman equationA Volosov, M Bialer

Biopharmaceutics & Drug Disposition|March 23, 1999

Possible factor for nonlinear pharmacokinetics of TAK-603, a new antirheumatic agent, in ratsY Tagawa, K Miwa, K Yamashita, et al.

Biopharmaceutics & Drug Disposition|March 23, 1999

Intravenous pharmacokinetics and absolute oral bioavailability of dolasetron in healthy volunteers: part 1D C Dimmitt, Y S Choo, L A Martin, et al.

Biopharmaceutics & Drug Disposition|March 23, 1999

Pharmacokinetics and electroencephalographic effects of ketoconazole in the ratT Kotegawa, B E Laurijssens, A L Durol, et al.

Biopharmaceutics & Drug Disposition|March 23, 1999

Absolute bioavailability of reboxetine enantiomers and effect of gender on pharmacokineticsJ C Fleishaker, M Mucci, C Pellizzoni, et al.

Biopharmaceutics & Drug Disposition|December 2, 2000

Modeling of dose-response-time data: four examples of estimating the turnover parameters and generating kinetic functions from response profilesJ Gabrielsson, W J Jusko, L Alari

Biopharmaceutics & Drug Disposition|February 17, 2001

Quantitative prediction of catalepsy induced by amoxapine, cinnarizine and cyclophosphamide in miceR Nasu, H Matsuo, H Takanaga, et al.

Biopharmaceutics & Drug Disposition|February 17, 2001

First measured plasma concentration value as C(max); impact on the C(max) confidence interval in bioequivalence studiesA Jackson, D Conner, R Miller

Biopharmaceutics & Drug Disposition|February 17, 2001

Effects of enzyme inducers or inhibitors on the pharmacokinetics of intravenous parathion in ratsE Hurh, E Lee, A Lee, et al.

Biopharmaceutics & Drug Disposition|January 11, 2023

Evaluation of bottom-up modeling of the blood-brain barrier to improve brain penetration prediction via physiologically based pharmacokinetic modelingChristine Bowman, Fang Ma, Jialin Mao, et al.

Pageof 214

Showing results (1631-1640 of 2,133) with videos related to

Sort By:

Pageof 214

Biopharmaceutics & Drug Disposition|March 23, 1999

Use of mean residence time to determine the magnitude of difference between rate constants and to calculate tmax in the Bateman equationA Volosov, M Bialer

Biopharmaceutics & Drug Disposition|March 23, 1999

Possible factor for nonlinear pharmacokinetics of TAK-603, a new antirheumatic agent, in ratsY Tagawa, K Miwa, K Yamashita, et al.

Biopharmaceutics & Drug Disposition|March 23, 1999

Intravenous pharmacokinetics and absolute oral bioavailability of dolasetron in healthy volunteers: part 1D C Dimmitt, Y S Choo, L A Martin, et al.

Biopharmaceutics & Drug Disposition|March 23, 1999

Pharmacokinetics and electroencephalographic effects of ketoconazole in the ratT Kotegawa, B E Laurijssens, A L Durol, et al.

Biopharmaceutics & Drug Disposition|March 23, 1999

Absolute bioavailability of reboxetine enantiomers and effect of gender on pharmacokineticsJ C Fleishaker, M Mucci, C Pellizzoni, et al.

Biopharmaceutics & Drug Disposition|December 2, 2000

Modeling of dose-response-time data: four examples of estimating the turnover parameters and generating kinetic functions from response profilesJ Gabrielsson, W J Jusko, L Alari

Biopharmaceutics & Drug Disposition|February 17, 2001

Quantitative prediction of catalepsy induced by amoxapine, cinnarizine and cyclophosphamide in miceR Nasu, H Matsuo, H Takanaga, et al.

Biopharmaceutics & Drug Disposition|February 17, 2001

First measured plasma concentration value as C(max); impact on the C(max) confidence interval in bioequivalence studiesA Jackson, D Conner, R Miller

Biopharmaceutics & Drug Disposition|February 17, 2001

Effects of enzyme inducers or inhibitors on the pharmacokinetics of intravenous parathion in ratsE Hurh, E Lee, A Lee, et al.

Biopharmaceutics & Drug Disposition|January 11, 2023

Evaluation of bottom-up modeling of the blood-brain barrier to improve brain penetration prediction via physiologically based pharmacokinetic modelingChristine Bowman, Fang Ma, Jialin Mao, et al.

Pageof 214